首页> 外文期刊>Therapeutic Drug Monitoring >Prediction of tacrolimus blood levels by using the neural network with genetic algorithm in liver transplantation patients.
【24h】

Prediction of tacrolimus blood levels by using the neural network with genetic algorithm in liver transplantation patients.

机译:使用遗传算法的神经网络预测肝移植患者他克莫司的血药浓度。

获取原文
获取原文并翻译 | 示例
           

摘要

The neural network (NN) is a technique using an artificial intelligent concept in predicting outcomes by using various input variables. Tacrolimus pharmacokinetics has wide inter- and intra-subject variability and it is often difficult to predict its blood concentrations by dose alone. The objectives of this study are to select the clinically significant variables and to predict the blood concentration of tacrolimus in liver transplant patients by NN combined with genetic algorithm (GA). A total of thirty-two adult liver transplant patients from the University of Iowa Hospitals and Clinics were selected and the patients' data were retrospectively collected. These patient were randomly assigned into two groups: either the training group (n = 10), or testing group (n = 22). A back propagation (BP) NN was developed which contained two hidden layers. A dynamic BP NN based on the time series concept was trained by using the current and previous data sets to predict the trough levels of tacrolimus. The mean of the NN prediction for tacrolimus blood levels was not significantly different from the observed value by a paired t-test comparison (12.05+/-2.67 ng/ml vs. 12.14+/-2.64 ng/ml, p = 0.80). The average difference of the testing sets between the observed and predicted levels was 1.74 ng/ml with a range from 0.08 to 5.26 ng/ml which is clinically acceptable range. Thirty-seven out of 44 data sets (84%) in the testing group were within 3.0 ng/ml of the observed values. This study demonstrated that tacrolimus blood concentrations are precisely predictable in liver transplant patients using patients variables by NN.
机译:神经网络(NN)是一种使用人工智能概念通过使用各种输入变量来预测结果的技术。他克莫司的药代动力学具有广泛的受试者间和受试者内变异性,通常仅凭剂量很难预测其血药浓度。这项研究的目的是选择临床上重要的变量,并通过NN结合遗传算法(GA)预测肝移植患者他克莫司的血药浓度。共有来自爱荷华大学医院和诊所的32名成年肝移植患者入选,并回顾性收集了这些患者的数据。这些患者被随机分为两组:训练组(n = 10)或测试组(n = 22)。开发了包含两个隐藏层的反向传播(BP)NN。通过使用当前和先前的数据集来训练基于时间序列概念的动态BP神经网络,以预测他克莫司的谷水平。通过配对t检验比较,他克莫司血药浓度的NN预测平均值与观察值没有显着差异(12.05 +/- 2.67 ng / ml与12.14 +/- 2.64 ng / ml,p = 0.80)。测试组的观察值与预测值之间的平均差为1.74 ng / ml,范围为0.08至5.26 ng / ml,这是临床上可接受的范围。测试组中的44个数据集中有37个(84%)在观察值的3.0 ng / ml以内。这项研究表明,使用NN的患者变量,他克莫司的血药浓度在肝移植患者中是可以精确预测的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号